SQ injection of irradiated tumor cells expressing CCL20, followed by a second vaccination of DCs pulsed with irradiated tumor cells at the same injection site resulted in significantly more robust tumor rejection than DC vaccine alone [30]. The gene discussed is CCL20; the disease is neoplasm.